Aspect Partners’s Idexx Laboratories IDXX Stock Holding History

Aspect Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1K	Hold	4	–	–	﹤0.01%	507
2026 Q1	$2.25K	Hold	4	–	–	﹤0.01%	469
2025 Q4	$2.71K	Buy	4 +1	+33%	+$681	﹤0.01%	473
2025 Q3	$1.92K	Sell	3 -1	-25%	-$607	﹤0.01%	540
2025 Q2	$2.15K	Hold	4	–	–	﹤0.01%	465
2025 Q1	$1.68K	Hold	4	–	–	﹤0.01%	465
2024 Q4	$1.65K	Hold	4	–	–	﹤0.01%	491
2024 Q3	$2.02K	Hold	4	–	–	﹤0.01%	445
2024 Q2	$1.95K	Hold	4	–	–	﹤0.01%	462
2024 Q1	$2.16K	Hold	4	–	–	﹤0.01%	446
2023 Q4	$2.22K	Buy	+4	New	+$1.88K	﹤0.01%	430

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Aspect Partners's IDXX Position: Q2 2026 in Review

Aspect Partners held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 4 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #507.

Aspect Partners first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.71K in Q4 2025. 311 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Aspect Partners held 4 shares of Idexx Laboratories worth $2.1K as of Q2 2026.
Aspect Partners left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #507 holding.
Aspect Partners first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
Aspect Partners's Idexx Laboratories position peaked at $2.71K in Q4 2025.
311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.